Nachrichten zur Chimerix Inc. Aktie

Emergent (EBS) Acquires Worldwide Rights to Smallpox Antiviral

Emergent (EBS) completes the acquisition of worldwide rights to Tembexa, an FDA-approved smallpox oral antiviral for all ages, from Chimerix....…

Emergent BioSolutions Completes Acquisition of Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages

GAITHERSBURG, Md., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has…

Chimerix Announces Closing of TEMBEXA Sale to Emergent BioSolutions

- $238 Million in Upfront Payment Received at Closing with Additional $136.5 Million in Potential Milestone Payments Plus Royalties -...…

Chimerix: Affenpocken-Fall in China - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Chimerix-Aktienanalyse von "Der Aktionär": Andreas Deutsch vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

United Kingdom Monkeypox Therapeutics Market Report 2022-2027 Featuring Chimerix, SIGA Technologies, Emergent BioSolutions UK, Bavarian Nordic, Mylan, Olon S.p.A., & Teva

DUBLIN, Sept. 9, 2022 /PRNewswire/ -- The "United Kingdom Monkeypox Therapeutics Market, By Treatment (Smallpox Vaccine, Antivirals, Vaccinia Immune Globulin…

Form 8-K CHIMERIX INC For: Aug 26

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Chimerix Shares Jump After Smallpox Drug Supply Deal

Chimerix Shares Jump After Smallpox Drug Supply Deal...…

Chimerix gains on $551M U.S. contract for smallpox therapy

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Chimerix Awarded BARDA Contract for TEMBEXA as Medical Countermeasure for Smallpox

- Initial Procurement of 319,000 Treatment Courses for $115M with Additional Procurements at BARDAs Discretion Over 10 Years –...…

Chimerix Reports Second Quarter 2022 Financial Results and Provides Operational Update

– ONC201 Phase 3 ACTION Study Planned to Initiate This Year –...…

Chimerix to Report Second Quarter 2022 Financial Results and Provide an Operational Update on August 8, 2022

DURHAM, N.C., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines…

Form 8-K CHIMERIX INC For: Jul 29

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pre-market Movers: Chimerix, FaZe, Energy Vault, SIGA Technologies, iHuman

AMSTERDAM (dpa-AFX) - The following are some of the stocks making big moves in Mondays pre-market trading (as of 06.55…

Thinking about buying stock in Synthetic Biologics, Revelation Biosciences, Geovax Labs, Chimerix, or Zymergen?

NEW YORK, July 25, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SYN, REVB, GOVX, CMRX, and ZY. To…

Form 8-K CHIMERIX INC For: Jun 28

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K CHIMERIX INC For: Jun 23

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Chimerix ticks higher on new order for smallpox therapy

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Chimerix gets up to $25.3 million contract from Canada for smallpox drug

...(Reuters) - Chimerix Inc said on Friday it had been awarded......…

Chimerix gets up to $25.3 mln contract from Canada for smallpox drug

...June 24 (Reuters) - Chimerix Inc said on Friday it had been awarded......…

Chimerix receives $9.3M international procurement agreement for monkeypox treatment

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Chimerix Announces $9.3 Million International TEMBEXA Procurement Agreement

DURHAM, N.C., June 23, 2022 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission it is to…

Bluebird Bio, Clovis Oncology, Chimerix drop as Truist flags liquidity concerns

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Chimerix to Present at Jefferies Global Healthcare Conference

DURHAM, N.C., June 01, 2022 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission it is to…

Insiderhandel: Aufsichtsrat kauft Aktien von Chimerix im Wert von 40.738$

Middleton, Fred A. - Aufsichtsrat - Tag der Transaktion: 2022-05-19...…

Insiderhandel: Aufsichtsrat kauft Aktien von Chimerix im Wert von 23.470$

Meyer, Robert J. - Aufsichtsrat - Tag der Transaktion: 2022-05-19...…

Thinking about buying stock in Chimerix, AT&T, Canada Goose, Kodiak Sciences, or Torm?

NEW YORK, May 19, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CMRX, T, GOOS, KOD, and TRMD. To…

Form 8-K CHIMERIX INC For: May 15

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: Chief Business Officer and CFO kauft Aktien von Chimerix im Wert von 25.635$

Andriole, Michael T. - Vorstand - Tag der Transaktion: 2022-05-17...…

Chimerix to Present at H.C. Wainwright Global Investment Conference

DURHAM, N.C., May 17, 2022 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission it is to develop…

Chimerix (CMRX) Plunges on Unfavorable Pipeline Updates

The development of Chimerixs (CMRX) lead candidate, ONC201, gets delayed as the FDA states that data from the retrospective study…

Chimerix stock price target cut to $6 from $20 at Maxim Group

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

Chimerix (CMRX) Q1 2022 Earnings Call Transcript

CMRX earnings call for the period ending March 31, 2022....…

Chimerix Shares Slide; to Stop Investing in DSTAT Program

Chimerix Shares Slide; to Stop Investing in DSTAT Program...…

Thinking about buying stock in Sundial Growers, Veru, Chimerix, Vroom, or Rivian Automotive?

NEW YORK, May 16, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNDL, VERU, CMRX, VRM, and RIVN. To…

Chimerix Shares Plummet After Divesting Its Only Marketed Product For Over $300M

Form 10-Q CHIMERIX INC For: Mar 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K CHIMERIX INC For: May 16

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Chimerix stock surges after deal to sell smallpox treatment Tembexa for up to $337.5 million, plus royalties

Shares of Chimerix Inc. shot up 14.4% in premarket trading Monday, after the biopharmaceutical company said it will sell…

Emergent BioSolutions to Acquire from Chimerix its Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages

GAITHERSBURG, Md., May 16, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has…